Introduction
============

In recent years there has been an increasing interest in the chemistry of 4(3*H*)-quinazolinones because of their biological significance. Many of them show antifungal, antibacterial, anticancer, anti-inflammatory, anticonvulsant, immunotropic, hypolipidemic, antitumor, antiulcer analgesic and antiproliferative activities as well as inhibitory effects for thymidylate synthase and poly-(*ADP*-ribose) polymerase (*PARP*) \[[@B1-molecules-08-00401],[@B2-molecules-08-00401],[@B3-molecules-08-00401],[@B4-molecules-08-00401],[@B5-molecules-08-00401],[@B6-molecules-08-00401],[@B7-molecules-08-00401],[@B8-molecules-08-00401],[@B9-molecules-08-00401],[@B10-molecules-08-00401],[@B11-molecules-08-00401],[@B12-molecules-08-00401],[@B13-molecules-08-00401]\]. On the other hand, heterocycles containing the pyridazine nucleus also exhibit various pharmacological activities; reduction of blood pressure \[[@B14-molecules-08-00401]\], anticonvulsant activity \[[@B15-molecules-08-00401]\] and moreover there are pyridazine derivatives that have shown an interesting affinity towards *A~1~*-receptors, and are potentially usable as cerebroprotective agents \[[@B16-molecules-08-00401],[@B17-molecules-08-00401]\]. Because of these established biological activities, and within the framework of our systematic studies of new heterocyclic compounds with biological activity \[[@B18-molecules-08-00401],[@B19-molecules-08-00401],[@B20-molecules-08-00401],[@B21-molecules-08-00401]\], we became interested in the synthesis of a series of novel 4(3*H*)-quinazolinone derivatives containing a pyridazine ring, with the aim of obtaining annelated pyridazinoquinazolines with enhanced biological significance. This contribution represents a follow-up on our previous work on the chemistry of *N*-chlorosuccinimide (NCS) \[[@B22-molecules-08-00401],[@B23-molecules-08-00401],[@B24-molecules-08-00401]\].

Results and Discussion
======================

The starting material 3-amino-2-methyl-4(3*H*)-quinazolinone (**2**) was prepared by condensation of 2-methyl-3,1-benzoxazin-4-one (**1**) with hydrazine hydrate as described in the literature \[[@B25-molecules-08-00401]\]. It was then reacted with NCS to yield *in situ* the respective 3-amino-2-chloromethyl-4(3*H*)-quinazolinone (**3**), which was isolated and its structure confirmed on the basis of analytical and spectral data. This reaction constitutes a new and facile procedure for the synthesis of this reactive compound \[[@B26-molecules-08-00401]\]. Compound **3** was then treated with triethylamine (TEA) to afford the zwitterion **4**, created by the loss of HCl ([Scheme 1](#molecules-08-00401-f001){ref-type="scheme"}). This zwitterionic species **4** was used as the key intermediate for the present study. Thus, the behavior of **4** towards the *N*-arylmaleimides **5a-d** was investigated with regards to the synthesis of annelated quinazolines. It was found that compound **2** reacted with *N*-phenylmaleimide (**5a**) in the presence of NCS and TEA in dry chloroform with stirring for 1 h at room temperature to give a reaction product of molecular formula C~19~H~14~N~4~O~3~ which corresponds to the addi­tion of one molecule of **2** to one molecule of **5a,** with subsequent elimination of a HCl molecule. The IR spectrum of this product showed the pres­ence of NH (3340 cm^-1^), C*=*O (1680 cm^-1^), saturated CH~2~ and CH (2980 cm^-1^) and C*=*N groups (1635 cm^-1^), in addition to the CO-NAr-CO group, which appears as two widely separated bands \[[@B27-molecules-08-00401]\] at 1780 and 1710 cm^-1^. Its ^1^H-NMR spectrum revealed the presence of signals for the pyridazine H-3 and H-4, pyridazine-CH~2~, NH and aromatic protons in their proper positions (*cf.* Experimental). Based on the above data, this product was formulated as 2-phenyl-3a,4,12,12a-tetrahydropyrrolo\[3\',4\':4,3\]-pyridazino\[6,1-*b*\]quinazoline-1,3,6-trione (**6a**). The formation of **6a** is assumed to proceed *via* the initial reaction of **2** with NCS to yield 3-amino-2-chloromethyl-4(3*H*)-quinazolinone (**3**), which is not isolated, but rather reacts *in situ* with TEA to give the zwitterionic intermediate **4,** which in turn reacts with **5a** *via* a dipolar cycloaddition to yield the final isolable pyrrolopyridazinoquinazoline derivative **6a**. This constitutes a simple and easy one pot reaction leading to a fused heterocyclic derivative which otherwise is difficult to obtain. A similar reaction with maleimides has been described in our earlier communications \[[@B23-molecules-08-00401],[@B24-molecules-08-00401]\]. Similarly, the diionic species **4** reacted with each of the *N*-arylmaleimides **5b-d**, under the same experimental conditions, to afford the corresponding tetrahydropyrrolo\[3\',4\':4,3\]pyridazino\[6,1-*b*\]quinazolinetrione derivatives **6b-d**, respectively, whose structure was based also on correct elemental analyses and spectroscopic data studies (*cf.* Experimental).

![](molecules-08-00401-g001){#molecules-08-00401-f001}

Additional confirmation of the structures of **6a-d** came from their dehydrogenation using boiling nitrobenzene to yield the corresponding pyrrolo\[3\',4\':4,3\]-pyridazino\[6,1-*b*\]quinazoline-1,3,6-triones **7a-d**, respectively ([Scheme 1](#molecules-08-00401-f001){ref-type="scheme"}). The structure of the latter products was also confirmed by their elemental analyses and spectral data. Thus, the IR spectra of compounds **7a-d** displayed bands assignable to NH and saturated CH~2~ groups, while their ^1^H-NMR spectra revealed only the presence of signals for pyridazine H-5 and aromatic protons (and for CH~3~ or OCH~3~ if present). No pyridazine H-3 or H-4 signals were detected in these spectra which were found to be in accordance with the expected outcome of the proposed dehydrogenation reaction (*cf.* Experimental).

As a continuation of our studies aimed at synthesizing pyridazinoquinazoline derivatives with potential biological activity, the behavior of the zwitterionic species **4** towards a variety of 3-aryl-2-cyanothioacrylamides **8a-d** was also examined. Thus, **4** reacted in chloroform with 3-phenyl-2-cyanothioacrylamide (**8a**) to give the respective 10-oxopyridazino\[6,1-*b*\]quinazoline-3-thiocarboxamide structure **10a** ([Scheme 2](#molecules-08-00401-f002){ref-type="scheme"}).
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Formation of **10a** is assumed to proceed *via* addition of the NH in **4** to the activated *α*,*β*-unsaturated center in **8a**, affording the cyclic adduct **9a** which spontaneously aromatizes to the final product **10a** *via* elimination of a HCN molecule and subsequent dehydrogenation. The IR spectrum of this product showed the bands of NH~2~, C*=*O and C*=*S groups. Moreover, its ^1^H-NMR spectrum revealed the presence of signals corresponding to the presence of NH~2~ function, in addition to the pyridazine CH and aromatic protons in their proper positions (*cf.* Experimental). In the same way, each of **8b-d** also reacted with **4** to yield the corresponding pyridazinoquinazolines **10b-d**, respect­ively, whose structures was similarly established based on elemental analysis and spectral data.

As an extension of this synthetic route, the behavior of **4** towards various *ω*-nitrostyrenes **11a-d** was also studied. Thus, compound **2** and NCS in chloroform and TEA (*i.e.* **4**) reacted with **11a-d** to yield the corresponding 3-nitrotetrahydropyridazino\[6,1-*b*\]quinazolin-10-ones **12a-d**, respective­ly ([Scheme 2](#molecules-08-00401-f002){ref-type="scheme"}). Both elemental analyses and spectral data of the latter products were consistent with the assigned structures. Bands of NH and saturated CH~2~ groups appeared in their IR spectra, while their ^1^H-NMR spectra confirmed the presence of these groups, in addition to two pyridazine-CH and aromatic protons, in each case (*cf.* Experimental).

The 1,2,3,4-tetrahydro derivatives **12a-d** could also be dehydrogenated by the action of boiling nitrobenzene to afford the corresponding 2-aryl-3-nitropyridazino\[6,1-*b*\]quinazolin-10-ones **13a-d** ([Scheme 2](#molecules-08-00401-f002){ref-type="scheme"}). No absorption bands for NH groups were detected in the IR spectra of **13a-d**. Additionally, their ^1^H-NMR spectra revealed the complete absence of pyridazine-CH, pyridazine-CH~2~ and NH signals while they revealed only the presence of signals for pyridazine H-5 and aromatic protons (and for OCH~3~ if present).

Experimental
============

General
-------

All melting points are uncorrected. IR (KBr discs) were recorded on Perkin Elmer FT--IR type 4 spectrophotometer. ^1^H-NMR Spectra were recorded on Gemini 200 MHz Spectrometer using TMS as an internal standard. ^13^C-NMR spectra were recorded using a Varian Mercuy 300 NMR Spectrometer. Mass spectra were recorded on AEI MS 30 mass spectrometer operating at 70eV. Compounds **1** \[[@B28-molecules-08-00401]\], **2** \[[@B25-molecules-08-00401]\], **5** \[[@B29-molecules-08-00401]\] and **11** \[[@B30-molecules-08-00401]\] were prepared according to the reported literature procedures.

Synthesis of 3-amino-2-chloromethyl-4(3H)-quinazolinone (**3**) \[[@B26-molecules-08-00401]\].
----------------------------------------------------------------------------------------------

A solution of **2** (0.01 mol) in dry chloroform (10 mL) containing pyridine (2 drops) was stirred with NCS (0.01 mol) for 20 min. Removal of the solvent gave a residue which was recrystallized from ethanol to give the title compound as colorless crystals, yield 98%, m.p. 156°C; Anal. Calcd. for C~9~H~8~ClN~3~O: C, 51.56; H, 3.84; N, 20.04; Cl, 16.91%; Found: C, 51.8; H, 3.9; N, 20.3; Cl, 17.1%; IR: *ν* *=* 3400, 3350 (NH~2~), 2980 (sat. CH~2~), 1680 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 4.51 (s, 2H, CH~2~), 5.90 (br s, 2H, NH~2~), 7.30-7.92 (m, 4H, H-arom.) ppm.

General Procedure for the Synthesis of 2-aryl-3a,4,12,12a-tetrahydropyrrolo\[3\',4\':4,3\]-pyridazino-\[6,1-b\]quinazoline-1,3,6-triones *(**6a--d**)*, 2-aryl-10-oxopyridazino\[6,1-b\]quinazoline-3-thio-carboxamides *(**10a--d**)* and 2-aryl-3-nitro-1,2,3,4-tetrahydropyridazino\[6,1-b\]quinazolin-10-ones *(**12a--d**)*.
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To a solution of NCS (0.01 mol) in dry chloroform (30 mL) and pyridine (2 drops), compound **2** (0.01 mol) was added and stirred for 20 min. To this solution, each of the appropriate *N*-aryl­maleimides **5a--d**, 3-aryl-2-cyanothioacrylamides **8a--d** or *ω*-nitrostyrenes **11a--d** (0.015 mol) was added and the reaction mixture was stirred for additional 10 min. at room temperature. A solution of TEA (0.12 mol) in dry chloroform (5 mL) was added dropwise over *ca.* 30 min. Stirring was continued for an extra 60 min. then the solution was washed with water (2x15 mL), dried and evaporated *in vacuo*. The residues were triturated and recrystallized from ethanol to yield **6a-d**, **10a-d** and **12a--d**, respectively.

**6a:** Brown crystals, yield 90%, m.p. 168°C; Anal. Calcd. for C~19~H~14~N~4~O~3~: C, 65.89; H, 4.07; N, 16.17%; Found: C, 66.1; H, 4.2; N, 16.4%; IR: *ν* *=* 3340 (NH), 2980 (sat. CH~2~ and CH), 1780, 1710 (CO-NAr-CO), 1680 (C*=*O), 1635 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 3.61 (m, 1H, pyridazine H-4), 4.22 (d, 1H, *J =* 6.4 Hz, pyridazine H-3), 4.50 (d, 2H, *J =* 6.0 Hz, pyridazine-CH~2~), 7.01-7.81 (m, 9H, H-arom.), 9.92 (br s, 1H, NH) ppm; MS: *m/z* *=* 346 (M^+^, 18%).

**6b:** Brown crystals, yield 92%, m.p. 185°C; Anal. Calcd. for C~19~H~13~ClN~4~O~3~: C, 59.93; H, 3.44; N, 14.71%; Cl, 9.31; Found: C, 60.1; H, 3.6; N, 14.8; Cl, 9.5%; IR: *ν* *=* 3350 (NH), 2985 (sat. CH~2~ and CH), 1770, 1720 (CO-NAr-CO), 1685 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (DMSO-d~6~): *δ* *=* 3.62 (m, 1H, pyridazine H-4), 4.13 (d, 1H, *J =* 6.5 Hz, pyridazine H-3), 4.55 (d, 2H, *J =* 6.0 Hz, pyridazine-CH~2~), 7.19-7.87 (m, 8H, H-arom.), 10.14 (br s, 1H, NH) ppm.

**6c:** Brown crystals, yield 95%, m.p. 95°C; Anal. Calcd. for C~20~H~16~N~4~O~4~: C, 63.82; H, 4.28; N, 14.88%; Found: C, 63.7; H, 4.1; N, 14.7%; IR: *ν* *=* 3350 (NH), 2982 (sat. CH~2~ and CH), 1780, 1710 (CO-NAr-CO), 1670 (C*=*O), 1635 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 3.60 (m, 1H, pyridazine H-4), 3.82 (s, 3H, OCH~3~), 4.20 (d, 1H, *J =* 6.5 Hz, pyridazine H-3), 4.61 (d, 2H, *J =* 6.1 Hz, pyridazine-CH~2~), 7.11-7.80 (m, 8H, H-arom.), 9.83 (br s, 1H, NH) ppm.

**6d:** Brown crystals, yield 80%, m.p. 170°C; Anal. Calcd. for C~20~H~16~N~4~O~3~: C, 66.65; H, 4.47; N, 15.54%; Found: C, 66.4; H, 4.6; N, 15.7%; IR: *ν* *=* 3330 (NH), 2980 (sat. CH~2~ and CH), 1770, 1715 (CO-NAr-CO), 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 1.60 (s, 3H, CH~3~), 3.65 (m, 1H, pyridazine H-4), 4.05 (d, 1H, *J =* 6.3 Hz, pyridazine H-3), 4.65 (d, 2H, *J =* 5.9 Hz, pyridazine-CH~2~), 7.00-7.71 (m, 8H, H-arom.), 9.90 (br s, 1H, NH) ppm.

**10a:** Brown crystals, yield 80%, m.p. 184°C; Anal. Calcd. for C~18~H~12~N~4~OS: C, 65.04; H, 3.63; N, 16.85; S, 9.64%; Found: C, 65.3; H, 3.8; N, 16.7; S, 9.4%; IR: *ν* *=* 3400, 3380 (NH~2~), 1670 (C*=*O), 1630 (C*=*N), 1580 (C=S) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 6.55 (s, 1H, pyridazine H-5), 7.15-7.98 (m, 9H, H-arom.), 9.99 (br s, 2H, NH~2~) ppm; MS: *m/z* *=* 332 (M^+^, 15%).

**10b:** Yellow crystals, yield 75%, m.p. 137°C; Anal. Calcd. for C~18~H~11~ClN~4~OS: C, 58.93; H, 3.02; N, 15.27; S, 8.74; Cl, 9.66%; Found: C, 59.2; H, 3.1; N, 15.6; S, 8.4; Cl, 9.5%; IR: *ν* *=* 3410, 3370 (NH~2~), 1675 (C*=*O), 1630 (C*=*N), 1585 (C*=*S) cm^-1^; ^1^H-NMR (DMSO-d~6~): *δ* *=* 6.45 (s, 1H, pyridazine H-5), 7.04-7.86 (m, 8H, H-arom.), 9.97 (br s, 2H, NH~2~) ppm.

**10c:** Yellow crystals, yield 95%, m.p. 200°C; Anal. Calcd. for C~19~H~14~N~4~O~2~S: C, 62.97; H, 3.89; N, 15.46; S, 8.84%; Found: C, 62.7; H, 4.0; N, 15.7; S, 8.6%; IR: *ν* *=* 3390, 3350 (NH~2~), 1670 (C*=*O), 1630 (C*=*N), 1600 (C*=*S) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 3.81 (s, 3H, OCH~3~), 6.40 (s, 1H, pyridazine H-5), 7.02-7.80 (m, 8H, H-arom.), 9.91 (br s, 2H, NH~2~) ppm.

**10d:** Brown crystals, yield 90%, m.p. 145°C; Anal. Calcd. for C~18~H~11~N~5~O~3~S: C, 57.29; H, 2.92; N, 18.57; S, 8.49%; Found: C, 57.3; H, 3.1; N, 18.3; S, 8.7%; IR: *ν* *=* 3380, 3360 (NH~2~), 1670 (C*=*O), 1630 (C*=*N), 1590 (C*=*S) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 6.52 (s, 1H, pyridazine H-5), 7.02-7.80 (m, 8H, H-arom.), 9.95 (br s, 2H, NH~2~) ppm.

**12a:** Brown crystals, yield 81%, m.p. 273°C; Anal. Calcd. for C~17~H~14~N~4~O~3~: C, 63.34; H, 4.37; N, 17.38%; Found: C, 63.6; H, 4.7; N, 17.7%; IR: *ν* *=* 3350 (NH), 2980 (sat. CH~2~ and CH), 1675 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (DMSO-d~6~): *δ* *=* 3.62 (m, 1H, pyridazine H-4), 4.16 (d, 1H, *J =* 6.3 Hz, pyridazine H-3), 4.55 (d, 2H, *J =* 5.9 Hz, pyridazine-CH~2~), 7.19-7.88 (m, 9H, H-arom.), 9.78 (br s, 1H, NH) ppm; MS: *m/z* *=* 322 (M^+^, 25%).

**12b:** Colorless crystals, yield 95%, m.p. 205°C; Anal. Calcd. for C~17~H~13~ClN~4~O~3~: C, 57.22; H, 3.65; N, 15.71; Cl, 9.96%; Found: C, 57.4; H, 3.8; N, 15.5; Cl, 10.1%; IR: *ν* *=* 3320 (NH), 2985 (sat. CH~2~ and CH), 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 3.65 (m, 1H, pyridazine H-4), 4.15 (d, 1H, *J =* 6.3 Hz, pyridazine H-3), 4.57 (d, 2H, *J =* 6.0 Hz, pyridazine-CH~2~), 7.06-7.71 (m, 8H, H-arom.), 9.69 (br s, 1H, NH) ppm.

**12c:** Yellow crystals, yield 88%, m.p. 245°C; Anal. Calcd. for C~18~H~16~N~4~O~4~: C, 61.36; H, 4.57; N, 15.90%; Found: C, 61.6; H, 4.8; N, 15.7%; IR: *ν* *=* 3350 (NH), 2980 (sat. CH~2~ and CH), 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 3.61 (m, 1H, pyridazine H-4), 3.82 (s, 3H, OCH~3~), 4.20 (d, 1H, *J =* 6.4 Hz, pyridazine H-3), 4.51 (d, 2H, *J =* 6.0 Hz, pyridazine-CH~2~), 7.11-7.70 (m, 8H, H-arom.), 9.92 (br s, 1H, NH) ppm.

**12d:** Yellow crystals, yield 78%, m.p. 265°C; Anal. Calcd. for C~17~H~13~N~5~O~5~: C, 55.59; H, 3.54; N, 19.07%; Found: C, 55.8; H, 3.5; N, 19.2%; IR: *ν* *=* 3360 (NH), 2985 (sat. CH~2~ and CH), 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (DMSO-d~6~): *δ* *=* 3.65 (m, 1H, pyridazine H-4), 4.33 (d, 1H, *J =* 6.5 Hz, pyridazine H-3), 4.55 (d, 2H, *J =* 6.1 Hz, pyridazine-CH~2~), 7.12-7.80 (m, 8H, H-arom.), 10.10 (br s, 1H, NH) ppm.

General Procedure for the Synthesis of 2-arylpyrrolo\[3\',4\':4,3\]pyridazino\[6,1-b\]quinazoline-1,3,6-triones ***7a--d*** and 2-aryl-3-nitropyridazino\[6,1-b\]quinazolin-10-ones ***13a--d***
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A solution of each of **6a-d** and **12a-d** (1.0 g) was heated in nitrobenzene (15 mL) for 5 h. Nitrobenzene was steam distilled and the organic compound was extracted with ether. Removal of ether gave a residue which was crystallized from ethanol to give **7a-d** and **13a-d**, respectively.

**7a:** Brown crystals, yield 85%, m.p. 118°C; Anal. Calcd. for C~19~H~10~N~4~O~3~: C, 66.66; H, 2.94; N, 16.36%; Found: C, 66.8; H, 3.1; N, 16.6%; IR: *ν* *=* 1780, 1720 (CO-NAr-CO), 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 6.30 (s, 1H, pyridazine H-5), 7.10-7.91 (m, 9H, H-arom.) ppm; MS: *m/z =* 342 (M^+^, 21%).

**7b:** Brown crystals, yield 85%, m.p. 215°C; Anal. Calcd. for C~19~H~9~ClN~4~O~3~: C, 60.56; H, 2.39; N, 14.87%; Cl, 9.43; Found: C, 60.4; H, 2.4; N, 14.6; Cl, 9.3%; IR: *ν* *=* 1785, 1715 (CO-NAr-CO), 1675 (C*=*O), 1640 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 6.42 (s, 1H, pyridazine H-5), 7.00-7.81 (m, 8H, H-arom.) ppm.

**7c:** Brown crystals, yield 90%, m.p. 160°C; Anal. Calcd. for C~20~H~12~N~4~O~4~: C, 64.51; H, 3.25; N, 15.04%; Found: C, 64.7; H, 3.4; N, 15.3%; IR: *ν* *=* 1780, 1710 (CO-NAr-CO), 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 3.80 (s, 3H, OCH~3~), 6.41 (s, 1H, pyridazine H-5), 7.10-7.82 (m, 8H, H-arom.) ppm.

**7d:** Brown crystals, yield 92%, m.p. 209°C; Anal. Calcd. for C~20~H~12~N~4~O~3~: C, 67.41; H, 3.39; N, 15.72%; Found: C, 67.6; H, 3.7; N, 15.9%; IR: *ν* *=* 1770, 1720 (CO-NAr-CO), 1670 (C*=*O), 1635 (C*=*N) cm^-1^; ^1^H-NMR (DMSO-d~6~): *δ* *=* 1.65 (s, 3H, CH~3~), 6.42 (s, 1H, pyridazine H-5) 7.28-7.86 (m, 8H, H-arom.) ppm; ^13^C-NMR (DMSO-d~6~): *δ* *=* 21.5 (CH~3~), 117.6, 123.2, 125.1, 125.7, 126.2, 126.9, 127.8, 128.1, 129.4, 130.3, 134.5, 136.2, 144.0, 147.7 (C-arom.), 155.5 (C-6), 170.1, 171.3 (C-1, C-3) ppm.

**13a:** Brown crystals, yield 84%, m.p. \> 300°C; Anal. Calcd. for C~17~H~10~N~4~O~3~: C, 64.15; H, 3.16; N, 17.60%; Found: C, 64.3; H, 3.4; N, 17.9%; IR: *ν* *=* 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (DMSO-d~6~): *δ* *=* 6.66 (s, 1H, pyridazine H-5), 7.05-7.80 (m, 9H, H-arom.) ppm; MS: *m/z* *=* 318 (M^+^, 32%); ^13^C- NMR (DMSO-d~6~): *δ* *=* 117.3, 123.6, 125.4, 125.8, 126.2, 126.7, 127.0, 127.3, 128.3, 129.8, 131.4, 148.5, 151.2, 153.0 (C-arom.), 155.3 (C*=*O) ppm.

**13b:** Brown crystals, yield 95%, m.p. 280°C; Anal. Calcd. for C~17~H~9~ClN~4~O~3~: C, 57.87; H, 2.55; N, 15.89; Cl, 10.07%; Found: C, 57.9; H, 2.3; N, 16.0; Cl, 10.1%; IR: *ν* = 1675 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (DMSO-d~6~): *δ* *=* 6.68 (s, 1H, pyridazine H-5), 7.25-7.91 (m, 8H, H-arom.) ppm.

**13c:** Brown crystals, yield 77%, m.p. \> 300°C; Anal. Calcd. for C~18~H~12~N~4~O~4~: C, 62.07; H, 3.47; N, 16.08%; Found: C, 62.3; H, 3.7; N, 16.2%; IR: *ν* *=* 1670 (C*=*O), 1630 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 3.85 (s, 3H, OCH~3~), 6.61 (s, 1H, pyridazine H-5), 7.11-7.80 (m, 8H, H-arom.) ppm.

**13d:** Brown crystals, yield 90%, m.p. \> 300°C; Anal. Calcd. for C~17~H~9~N~5~O~5~: C, 56.20; H, 2.48; N, 19.28%; Found: C, 56.1; H, 2.6; N, 19.3%; IR: *ν* *=* 1675 (C*=*O), 1635 (C*=*N) cm^-1^; ^1^H-NMR (CDCl~3~): *δ* *=* 6.71 (s, 1H, pyridazine H-5), 7.02-7.75 (m, 8H, H-arom.) ppm.
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